宫颈癌患者放化疗期间症状群的影响因素

Influencing factors in patients with cervical cancer during chemoradiotherapy

  • 摘要:
    目的  分析宫颈癌患者放化疗期间症状群的影响因素。
    方法  回顾性分析776例确诊为宫颈癌并进行放化疗患者的临床资料。采用安德森症状评估量表(MDASI-D)评估癌症患者的常见症状及其严重程度。采用探索性因子分析提取症状群。采用单因素和多重线性回归分析筛选主要症状群的影响因素。
    结果  776例宫颈癌放化疗患者中, 发生率前5位的症状依次是疲乏、恶心、口干、睡眠不安和呕吐。通过探索性因子分析,共提取出消化道症状群、躯体症状群、副作用症状群及情感症状群这4个症状群。多元线性回归分析显示,年龄、美国东部肿瘤协作组(ECOG)评分为宫颈癌放化疗患者消化道症状群的影响因素(P < 0.05); 年龄、文化程度、疾病分期、ECOG评分为宫颈癌放化疗患者躯体症状群的影响因素(P < 0.05); 年龄、文化程度、家庭人均月收入、ECOG评分、疾病分期为宫颈癌放化疗患者情感症状群的影响因素(P < 0.05); ECOG评分、疾病分期、合并慢性病为宫颈癌放化疗患者副作用症状群的影响因素(P < 0.05)。
    结论  宫颈癌患者放化疗期间常出现消化道、情感、躯体及副作用症状群。

     

    Abstract:
    Objective  To analyze the influencing factors of symptom clusters during chemoradiotherapy in patients with cervical cancer.
    Methods  A retrospective analysis was conducted on the clinical data of 776 patients diagnosed with cervical cancer during chemoradiotherapy. The M.D. Anderson Symptom Inventory(MDASI-D)was used to assess common symptoms and their severity in cancer patients. Exploratory factor analysis was employed to extract symptom clusters. Univariate and multiple linear regression analyses were performed to screen for influencing factors of the major symptom clusters.
    Results  Among 776 cervical cancer patients undergoing chemoradiotherapy, the five most prevalentsymptoms were fatigue, nausea, dry mouth, disturbed sleep and vomiting. Through exploratory factor analysis, a total of four symptom clusters, namely the digestive tract symptom cluster, the somatic symptom cluster, the side effect symptom cluster and the emotional symptom cluster were extracted. Multiple linear regression analysis revealed that age and Eastern Cooperative Oncology Group (ECOG) score were influencing factors for gastrointestinal symptom cluster (P < 0.05); age, educational level, disease stage and ECOG performance status were influencing factors for physical symptom cluster (P < 0.05); age, educational level, monthly household income per capita, ECOG performance status and disease stage were influencing factors for the emotional symptom cluster (P < 0.05); the ECOG performance status, disease stage and comorbid chronic diseases were influencing factors for the side effect symptom cluster (P < 0.05).
    Conclusion  Patients with cervical cancer frequently experience gastrointestinal, emotional, physical and side effect symptom clusters during chemoradiotherapy.

     

/

返回文章
返回